Group 1 - MiniMed Group Inc., a subsidiary of Medtronic plc, has priced its initial public offering (IPO) at $20.00 per share for 28 million shares [1] - The shares are set to begin trading on the Nasdaq Global Select Market on March 6, 2026, under the symbol "MMED," with the offering expected to close on March 9, 2026 [1] - MiniMed has granted underwriters a 30-day option to purchase up to 4.20 million additional shares at the initial public price [2] Group 2 - After the IPO, Medtronic is expected to retain approximately 90.03% ownership of MiniMed, which will decrease to 88.70% if the underwriters fully exercise their over-allotment option [3] - MiniMed plans to use a portion of the net proceeds from the offering for general corporate purposes, with any remaining funds allocated to repaying intercompany debt owed to Medtronic and for additional consideration related to asset transfers during the separation [3]